The latest edition of Treatment Review is available online, and in print. In addition, several Spanish language publications are now also available. All Network resources are available by fax, e-mail, and at www.atdn.org. There is no subscription fee to receive Information Bulletin, Treatment Review, The Simple Facts S
Information Bulletin is written and edited by The Network. Readers are informed of the source of materials when they have been written by other parties. This edition of Information Bulletin was written by Ken Fornataro and Lei Chou. None of the information contained in this publication should be construed as medical ad
Serostim is an injectable drug that has been approved by the federal government for the treatment of AIDS-related wasting syndrome. It has both anabolic, and anti-catabolic effects, meaning it builds muscle and prevents the breakdown of muscle as well. The effects typically last as long as you take the drug.
Syphilis rates in New York City have gone up once again. Last year they were double what they were in 2000. They went up another 50% in 2002. Most of the cases are among men who have sex with men (MSM). Men who have sex with men often don t identify as gay or homosexual, and some have sex with women as well. In additio
IL-2 has long been a source of controversy in the HIV arena. First off, it s shots. Usually lots of them for four or five weeks, then a break, then more weeks of shots. The side effects can be unpleasant, and in some cases severe. Considering the importance placed on CD4 cells counts, however, people have been willin
Pieces of this article are reprinted from a document that is posted on The New York State website. We ve shortened it to give you a brief overview. You can read the entire piece exactly as it was posted by calling for a copy or going to the web page listed at the end of this article. In the aftermath of the events of S
Although The United States Food and Drug Administration ( FDA ) approved the 20 minute HIV test, called the OraQuick Rapid HIV-1 Antibody Test, last year, just today the federal government expanded the number of places to get it done from 38,000 laboratory testing sites, to over 100,000 locations that include doctor s
Atazanavir, a protease inhibitor, is available on an Expanded Access Program (EAP) that doctors can enroll in their patients in by filling out a form and collecting data on how participants are doing. This drug is now no longer known as Zrivada, nor is it called TAZ. The Bristol-Myers Squibb Company has already enr
This letter was sent out to everyone on ADAP in New York State. Changes take effect February 15, 2003. At press time, things may seem to have improved, but a strong outcry of outrage is needed by members of the community. Contact you local, state and federal representatives and let them know how you feel. Do it now, be
Some people say that quitting smoking is harder than quitting heroin. Unless you ve been addicted to both cigarettes and heroin, you might not appreciate the comparison, but it s easy to find someone willing to say that they wished they had never started smoking. What most everyone who smokes has realized is that quitt
Viramune ( nevirapine ) is an anti-HIV drug that has been approved for many years. It was one of the first anti-HIV drugs approved. It has taken many years, many studies, and lots of real world experience to determine that Viramune is a very important anti-HIV drug.
The experimental drug T-20, known as Fuzeon, is about to be made available to 15,000 people. Actually, it s probably going to be approved by The FDA any day, and the company only has enough vials of the drug for 15,000 people worldwide for the year. In clinical trials, Fuzeon has performed well in people with few other
There are many words that health care providers use to describe the different types of rashes that people develop. There are so many different things that can cause rashes that whole books have been written about them. If you have a rash, tell your doctor or other health care professional. A rash could be a symptom of
This is the first edition of the newly revised Information Bulletin. What s the big difference? First off, it s not always going to be just about drugs. It s about being well, thinking and acting positive, creating health and supporting others. It s about trying to find a better way to live while getting rid of the hab
This information is designed to support, not replace, the relationship that exists between you and your doctor.